InvestorsHub Logo
Followers 380
Posts 15030
Boards Moderated 2
Alias Born 05/23/2009

Re: None

Saturday, 01/19/2019 3:18:51 PM

Saturday, January 19, 2019 3:18:51 PM

Post# of 182908
$NSPX people are absolutely insane to OVERLOOK her at these levels PERIOD. This IS THE PLAY of the OTC right now if you use the share structure vs price ALONE. 150 million A/S AT 0026??!! Shares SCARCE ANY WAY YOU TWIST IT. This is a MATHEMATICAL LOWFLOAT WIN with no fear whatsoever at this level. Even the BRAVEST SHORT will not dare touch her down here (if they have a brain). You have to be kidding me that rookies could possibly GIVE AWAY SHARES AT THESE LEVELS ON 150 MILLION A/S. If I have to explain such a fact to you then quit trading. NSPX IS TRADING AS IF ITS A SHELL, actually worse than that. ONLY ONE HUNDRED AND FIFTY MILLION A/S, I had to spell that out for you. THEN YOU ADD THE EXTRA SWEETNER HERE it's a #BIOTECH stock????!! WHAAAAAT??

$NSPX .0026?! READ ARTICLE BELOW IF YOU LOVE MONEY!!!!!!

NSPX NEW PROOF TO SHOW THEIR STUDIES ON MISPARGARIN STILL ON GOING AS LATE AS JUNE 18TH!! Although we dont need this as proof they already are partnering with Ridgeway pharmaceutical leading out their Compounds. A $1.8 billio. Hedgefund just took a 10% stake and a new 14c filing just came out.
https://adisinsight.springer.com/drugs/800030883

Traders dont know about NSPX and those that do are treating it as a shell. NAME A PHARMACEUTICAL COMPANY THAT has only 150 million A/S TRADING WITH 0031 on the ask??!! Name a pharmaceutical company with 150 million A/S BELOW 2 CENTS, GO AHEAD. Keep sleeping fellas.

I keep showing people the NUMEROUS CLUES that they are still working on all their projects. Even less than 3 months ago they silently released a PR that they licensed their Compounds out to Ridgeway and may make $12 million of the transaction PLUS ROYALTIES but gaga googie koolaid traders stick to their BLOATED SCAMS with no PRODUCTS and bashers just babble and seek my attention as I ignore them.

NSPX ONLY HAS 150 MILLION A/S and it less than 2 cents as A PHARMACEUTICAL?!

NSPX JUST HAD a filing a recently which showed that a $1.8 billion hedgefund just bought 10% of shares AND IT IS STILL BELOW 5 CENTS?

NSPX drug Mispargarin has been called the CANCER GRENADE is used when EVERYTHING ELSE HAS FAILED, could replace chemotherapy and has had PROVEN RESULTS on patients who were at THE MOST ADVANCED STAGES.
https://www.marketwatch.com/press-release/genspera-announces-positive-phase-ii-data-for-investigational-agent-mipsagargin-2015-01-16

ITS BREAKTHROUGH DRUG ON THE NEWS 0026? https://t.co/4xpVadG901

NSPX ONCE TRADED ON NASDAQ AS HOGH AS $250 PER SHARE! They are BIG BOARD MEMBERS and this is why the ticker is UNKNOWN TO PENNYSTOCK traders.

$NSPX big part getting Hamsen medical sold for $80million https://t.co/ZAaAukc4Ea

NSPX IS STILL PURSUING PARTNERS so they can move into the FINAL STAGE phase 3 of its trials so EXPECT A BUYOUT OR REVERSE MERGER AT SOME POINT IN TIME
https://xconomy.com/texas/2016/02/03/pursuing-partner-genspera-tests-toxin-based-drug-in-brain-cancer/

$NSPX See what Dr's R saying about its drug https://t.co/1PKOV8DPxx
#startup #crypto #Blockchain
#bitcoin #ICO

$NSPX not a TYPICAL OTC https://t.co/gOXBJmqkS3

https://phys.org/news/2017-05-successfully-cancer-agent-thapsigargin.amp?__twitter_impression=true

EVEN THEIR DR recieved the highest cancer award. Check out $NSPX Dr. Santosh Kesari, a recipient of the first annual Glioblastoma Multiforme Heroes Awards.
https://t.co/Om30Ky9HZ1

NSPX CAN RUN TO OVER $1 with just a tiny update of a BUYOUT candidate. 5 cents here is A GIVEN just by shares structure and INDUSTRY (BIOTECH) alone. I'll keep accumulating as traders snooze.

NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.